Bg Medicine Stock Revenue
| BGMDDelisted Stock | USD 0.0002 0.00 0.00% |
BG Medicine fundamentals help investors to digest information that contributes to BG Medicine's financial success or failures. It also enables traders to predict the movement of BGMD Pink Sheet. The fundamental analysis module provides a way to measure BG Medicine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BG Medicine pink sheet.
BGMD |
BG Medicine Company Revenue Analysis
BG Medicine's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current BG Medicine Revenue | 1.57 M |
Most of BG Medicine's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BG Medicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, BG Medicine reported 1.57 M of revenue. This is 99.98% lower than that of the Life Sciences Tools & Services sector and 99.91% lower than that of the Health Care industry. The revenue for all United States stocks is 99.98% higher than that of the company.
BGMD Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BG Medicine's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of BG Medicine could also be used in its relative valuation, which is a method of valuing BG Medicine by comparing valuation metrics of similar companies.BG Medicine is currently under evaluation in revenue category among its peers.
BGMD Fundamentals
| Return On Equity | -9.03 | ||||
| Return On Asset | -0.76 | ||||
| Operating Margin | (2.86) % | ||||
| Current Valuation | 545.97 K | ||||
| Shares Outstanding | 11.37 M | ||||
| Number Of Shares Shorted | 630.05 K | ||||
| Price To Earning | (0.06) X | ||||
| Price To Sales | 0.35 X | ||||
| Revenue | 1.57 M | ||||
| Gross Profit | 1.06 M | ||||
| EBITDA | (4.39 M) | ||||
| Net Income | (5.3 M) | ||||
| Cash And Equivalents | 1.52 M | ||||
| Cash Per Share | 0.14 X | ||||
| Debt To Equity | 5.31 % | ||||
| Current Ratio | 1.65 X | ||||
| Book Value Per Share | (0.17) X | ||||
| Cash Flow From Operations | (3.67 M) | ||||
| Short Ratio | 2.66 X | ||||
| Earnings Per Share | (0.72) X | ||||
| Target Price | 1.4 | ||||
| Beta | 83.44 | ||||
| Market Capitalization | 545.97 K | ||||
| Total Asset | 2.13 M | ||||
| Retained Earnings | (161.49 M) | ||||
| Working Capital | 771 K | ||||
| Current Asset | 1.95 M | ||||
| Current Liabilities | 1.18 M | ||||
| Net Asset | 2.13 M |
About BG Medicine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BG Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BG Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BG Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in BGMD Pink Sheet
If you are still planning to invest in BG Medicine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BG Medicine's history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |